Sansure Biotech Inc
SSE:688289
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sansure Biotech Inc
SSE:688289
|
CN |
|
Midatech Pharma PLC
LSE:MTPH
|
UK |
|
H
|
Herald Holdings Ltd
HKEX:114
|
HK |
|
H
|
Hydrogen Hybrid Technologies Inc
OTC:HYHY
|
CA |
|
AltaGas Ltd
TSX:ALA
|
CA |
|
A
|
APA Corp (US)
BMV:APA
|
US |
|
S
|
Suzhou YourBest New-type Materials Co Ltd
SZSE:301266
|
CN |
|
Atomo Diagnostics Ltd
ASX:AT1
|
AU |
|
A
|
Astra Graphia Tbk PT
IDX:ASGR
|
ID |
|
C
|
Compugates Holdings Bhd
KLSE:COMPUGT
|
MY |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
Renasant Corp
NYSE:RNST
|
US |
|
W
|
Wahana Inti Makmur Tbk PT
IDX:NASI
|
ID |
|
Cellectis SA
PAR:ALCLS
|
FR |
Wall Street
Price Targets
Price Targets Summary
Sansure Biotech Inc
According to Wall Street analysts, the average 1-year price target for Sansure Biotech Inc is 22.46 CNY with a low forecast of 22.24 CNY and a high forecast of 23.12 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sansure Biotech Inc's stock price target?
Price Target
22.46
CNY
According to Wall Street analysts, the average 1-year price target for Sansure Biotech Inc is 22.46 CNY with a low forecast of 22.24 CNY and a high forecast of 23.12 CNY.
What is Sansure Biotech Inc's Revenue forecast?
Projected CAGR
21%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's revenue is 30%. The projected CAGR for the next 3 years is 21%.
What is Sansure Biotech Inc's Operating Income forecast?
Projected CAGR
85%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's operating income is 70%. The projected CAGR for the next 1 year is 85%.
What is Sansure Biotech Inc's Net Income forecast?
Projected CAGR
16%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's net income is 85%. The projected CAGR for the next 3 years is 16%.
